Author: Bottomley Andrew Kirby Tony Bean John Walker Julie
Publisher: Informa Healthcare
ISSN: 1473-7167
Source: Expert Review of Pharmacoeconomics and Outcomes Research, Vol.13, Iss.1, 2013-02, pp. : 43-45
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Ensuring the quality of QOL instruments for use in clinical trials
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 462, 2004-01 ,pp. :
Rifaximin improves QoL in hepatic encephalopathy
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 603, 2010-01 ,pp. :
New legislation puts clinical trials in US "public arena"
Reactions Weekly, Vol. 1, Iss. 1176, 2007-01 ,pp. :
New US legislation puts clinical trials in "public arena"
Inpharma, Vol. 1, Iss. 1612, 2007-01 ,pp. :